Tag - dementia

 
Menu
Search
 
July 07, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

DEMENTIA

JAPAN / Science & Health
Aug 21, 2023
Japanese ministry panel gives OK to Alzheimer’s drug lecanemab
The panel’s endorsement will be followed by official approval by the health minister in coming days.
Japan Times
WORLD / Science & Health
Jul 17, 2023
Alzheimer's diagnosis revamp embraces rating scale similar to cancer
New guidelines would replace terminology such as mild, moderate and severe, instead using a numerical system related to disease progression.
Japan Times
BUSINESS / Companies
Jul 11, 2023
Eisai appoints CEO’s son to lead global Alzheimer drug program
Eisai's former global Alzheimer drug program officer, who led the push for U.S. approval of breakthrough medicine Leqembi, will retire at the end of the month.
Japan Times
WORLD / Science & Health
Jul 7, 2023
Eisai Alzheimer's drug gets full U.S. approval, widening access to the therapy
The broader clearance from the Food and Drug Administration marks a milestone for treatment of the dementia that afflicts some 6 million Americans.
Japan Times
JAPAN / Science & Health / FOCUS
Jul 4, 2023
Expectations grow for Alzheimer's drug in Japan, but hurdles remain
Lecanemab could be approved in the country as early as fall, but more specialist doctors and a patient screening system would be needed for widespread use.
Japan Times
COMMENTARY / World
Jul 3, 2023
Can we cure dementia before it starts?
Octogenarian and biologist Leroy Hood is trying to make the Elizabeth Holmes-ian dream of preventive medicine come true.
Japan Times
JAPAN / Society
Jun 22, 2023
Dementia-related missing person cases doubled over past 10 years
A total of 18,709 people with dementia were reported missing in 2022, up 6.1% from the previous year.
Japan Times
WORLD / Science & Health
Jun 19, 2023
New Eisai and Biogen Alzheimer drug faces hurdles in Europe
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price.
JAPAN / Science & Health
Jun 15, 2023
Parliament passes law aimed at supporting people with dementia
The health ministry expects the number of people with dementia in Japan to reach 7 million by 2025.
Japan Times
BUSINESS
Jun 1, 2023
Obesity and Alzheimer's news makes Eli Lilly world’s most valuable drugmaker
An 8.5% gain in May for Eli Lilly lifted its shares to a record high, while displaced Johnson & Johnson slumped 5.3% during the month.
Japan Times
COMMENTARY / World
May 17, 2023
A breakthrough on Alzheimer's is closer than ever
Promising data could open the door to insurance coverage for expensive new Alzheimer's drugs, bringing them closer to patients.
Japan Times
WORLD / Science & Health
Apr 6, 2023
Air pollution linked to increased dementia risk, Harvard researchers find
The World Health Organization recommends that average annual PM2.5 levels be below 5 micrograms — but nearly the entire global population breathes air that exceeds those limits.
Japan Times
ASIA PACIFIC
Jan 19, 2023
Asia turns to tech to help watch over a growing elderly population
Smart home technologies such as cameras, robots, motion sensors and artificial intelligence-based speakers are being rolled out to help take care of loved ones.
Japan Times
BUSINESS / Markets
Jan 10, 2023
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab
The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.
Japan Times
BUSINESS / Companies
Dec 28, 2022
Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough
Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer's biomarkers in blood tests.
Japan Times
JAPAN / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer’s
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug's trial success raises hope for Alzheimer's prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan braces for more quakes as authorities dismiss doomsday hype
Evacuees from Akuseki Island, located in the Tokara island chain in Kagoshima Prefecuture, arrive at Kagoshima Port on Friday.
Heatstroke alert issued for 19 prefectures as Japan enters 'once-in-a-decade' heat wave
Japan will experience a heat wave through mid-July on a “level only seen once in a decade,” the Meteorological Agency said on June 30.
Hidden AI prompts in academic papers spark concern about research integrity
Waseda University is one of 14 institutions in eight countries found to have used hidden prompts in research papers.
Tokyo and Kyoto feature among top ‘noctourism’ destinations
Tokyo ranked second after New York and ahead of Dubai and Singapore in a ranking of the top global cities for nighttime tourism.
Elon Musk says he has created a new U.S. political party
Elon Musk looks on during a news conference with U.S. President Donald Trump in the Oval Office of the White House in Washington on May 30.
Ainu land rights in crosshairs as Hokkaido communities debate nuclear waste
A street in Suttsu, Hokkaido, with a sign put up by an anti-nuclear organization. The small community is considering hosting a facility that would hold nuclear waste.
Ghibli’s Isao Takahata exhibit shows how beloved anime is made
“The man who planted Japanese animation” exhibition includes a variety of sketches, drawings and animation cels from Isao Takahata films such as color design for characters by Michiyo Yasuda from "Grave of the Fireflies."
Flag football facing challenges and opportunities ahead
Japan’s women’s flag football team at the 2025 International Bowl in Los Angeles in June. The sport is enjoying continued growth in the country.
From Hokusai’s Great Wave, shinkansen to One Piece: a cultural treasure box for Lego Japan
Michael Ebbesen, general manager of Lego Japan, says Lego bricks based on Japanese culture have a rich global appeal and are sellable around the world.
With farmed fish, RelationFish swims against the tide in fine dining
Chef Hideaki Matsuo (middle) and the staff of Oseto Suisan Fisheries prepare to check on their sustainably farmed fish.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji
By Alex K.T. Martin

SUSTAINABLE JAPAN

Muji has been sustainable from the beginning
Muji has been sustainable from the beginning

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER